Hwg Holdings LP Amgen Inc Transaction History

Hwg Holdings LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $184,139 - $219,277	-851 Closed	0 $0
Q3 2020 Oct 02, 2020	SELL	$234.65 - $260.95 $56,550 - $62,888	-241 Reduced 22.07%	851 $216,000
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $58,749 - $72,093	-297 Reduced 21.38%	1,092 $258,000
Q4 2019 Jan 09, 2020	BUY	$189.21 - $243.2 $262,812 - $337,804	1,389 New	1,389 $335,000
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $2,170 - $2,446	-12 Closed	0 $0
Q4 2018 Feb 19, 2019	BUY	$178.4 - $208.25 $1,070 - $1,249	6 Added 100.0%	12 $2,000
Q3 2018 Oct 19, 2018	BUY	$185.29 - $208.89 $1,111 - $1,253	6 New	6 $1,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

Stay updated on Hwg Holdings LP with notifications on news.